Fruquintinib Sequential BEV+FOLFIRI vs. BEV+FOLFIRI Sequential Fruquintinib in Metastatic Colorectal Cancer
NCT05447715
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
134
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Colorectal Cancer
Interventions
DRUG:
Fruquintinib
Sponsor
Weijian Guo